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ABSTRACT OF THESIS 
 
 
SYNTHESIS AND CHARACTERIZATION  
OF BLUE LIGHT POLY(β-AMINO ESTER)S 
 
 Volumetric muscle loss (VML) is a debilitating injury which results in full or 
partial loss of function. Current clinical options utilize tissue grafts and bracing to restore 
function. Tissue graft implantation oftentimes leads to serious complications, some of 
which end in graft rejection and thereby necessitate further surgeries and procedures. 
Polymeric scaffolds show promise as scaffolding systems due to their mechanical 
properties and overall degradation profiles. Scaffolds need appropriate mechanical 
properties, 10-60 kPa modulus, and overall degradation times, five days to two weeks, to 
initiate tissue regeneration. Poly(β-amino ester)s (PBAE), a class of synthetic polymers, 
act as a safe biocompatible material with overall degradation times that are suitable for 
healing; however, due to harmful ultraviolet light (UV) irradiation from common 
crosslinking methods, these scaffold systems cannot be synthesized in vivo. This research 
presents the development and characterization of blue light (BL) crosslinked PBAEs. BL 
PBAEs showed vastly higher swelling ratios, 300-400% increase; decreased mechanical 
strength, an average decrease of 877 kPa in compressive modulus and 431 kPa in tensile 
modulus; and prolonged degradation patterns, 22% average mass retention. BL PBAEs 
show mechanical properties and degradation profiles that could be used as a skeletal 
muscle scaffolds.   
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INTRODUCTION 
 Volumetric muscle loss is a debilitating injury where the body is unable to heal, 
resulting in full or partial loss of function. The primary cause of volumetric muscle loss 
involves instances of high tissue loss such as traumatic injuries and surgical procedures. 
Commonly this injury results in the development of necrotic tissues, decreased strength and 
reduced range of motion. Depending upon the severity of the injury, treatment can vary from 
simple bracing techniques to complex surgical procedures; all with the ultimate aim of 
restoring function to the damaged tissues. The standard of care for this injury is the 
implantation of tissue grafts into the wound area.  
 Tissue implantation, autologous or allogenic, have several complications that affect 
the success of the implant. Immune response, disease transmission, donor site morbidity, and 
decreased range of motion and strength are all possible complications that could arise from 
treatment. All of these complications pose the risk of graft failure, resulting in another 
surgery to further remove necrotic tissue costing more time and money. Logistically, the lack 
of available tissue grafts further diminishes the viability of this treatment strategy.  
 This research focused on the development and characterization of a blue light (BL) 
poly (β-amino ester) (PBAE) system with the long term aim of in vivo polymerization. This 
system utilized a BL irradiation source with its water-soluble photoinitiator to allow PBAE 
crosslinking. Against the common UV crosslinking method, PBAEs were characterized by 
examining their physical and mechanical properties, more specifically: degradation and 
swelling profiles, changes in supernatant pH, modulus under tension and compression, and 
hydrogel microarchitecture. Characterizing the physical and mechanical properties of the BL 
PBAE scaffolding system allows for better insights to its possible applications.  
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BACKGROUND AND SIGNIFICANCE 
Wound Healing Response 
 The wound healing response is a complex process involving many spatiotemporal 
overlapping processes including inflammation, tissue formation, and tissue remodeling [1-3]. 
Without any of these processes, healing cannot proceed and can lead to the development of 
chronic wounds. The wound healing process is shown in Figure 1. In normal wound healing 
immediately after occurrence of injury; vasoconstriction, of nearby vasculature, occurs as 
immune cells and platelets begin to flood to the wound area starting the clotting cascade. 
 
Figure 1: Summary of wound healing process. Adapted from Seifert, A.W., et al., Skin 
Regeneration in Adult Axolotls: A Blueprint for Scar-Free Healing in Vertebrates. PLoS 
ONE, 2012. 7(4): p. e32875. 
 As platelets invade the wound area they begin to come into contact with components 
of the extracellular matrix (ECM) causing release of numerous cytokines, chemokines, and 
growth factors; such as epidermal growth factor, transforming growth factor-β (TGF-β), 
vascular endothelial cell growth factor (VEGF), and platelet-derived growth factor (PDGF) 
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[1, 4, 5]. This release causes further platelet aggregation and recruitment of fibrinogen to the 
wound area for the formation of a platelet plug; while simultaneously, the fibrinogen is 
converted into fibrin by thrombin. Fibrin is crosslinked and further stabilized by factor XIII 
to form a fibrin clot; which serves for local cell adhesion, modulates cell responses, and acts 
as a reservoir for growth factors, proteases, and protease inhibitors [6]. 
 Near the end of the clotting cascade, the inflammation phase begins calling in 
multiple types of immune cells i.e. neutrophils, monocytes, and lymphocytes to the wound 
area, as seen in Figure 2 [4, 6]. Neutrophils are among the first immune cell to enter the 
wound area. Upon entering the wound area neutrophils begin to phagocytize any remnant 
tissue debris from the injury and form neutrophil extracellular traps to capture invading 
pathogens. These cells also have over 700 proteins stored inside including growth factors and 
pro-angiogenic factors, and upon activation can release these factors to aid in wound healing 
[7]. Apoptotic neutrophils aid in wound healing by releasing  tissue repairing cytokines i.e. 
TGB-β and Interlukin-10, further accelerating tissue repair [7]. Monocytes enter into the 
wound area and upon seeing the ECM become macrophages. These immune cells serve to 
remove spent neutrophils, apoptotic cells, and other debris; fight infection; promote and 
conclude inflammation; and secrete growth factors and cytokines e.g. TGF-β, transforming 
growth factor α (TGF-α), heparin binding epidermal growth factor, fibroblast growth factor 
(FGF), and collagenase that activate and recruit endothelial cells, fibroblasts, and 
keratinocytes to the wound site [2, 4-6]. Little is known about the last immune cell to enter 
the wound area, lymphocytes; but there is evidence to suggest they play a role in the 
reorganization of keratinocytes and fibroblasts [4, 8]. The proliferative phase, in parallel with 
the inflammatory phase, is identified by angiogenesis and the formation of granulation 
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tissues [1, 4, 6]. The cytokines and growth factors, produced by the clotting cascade, begin to 
recruit fibroblasts, keratinocytes, and endothelial cells to the wound. 
 
Figure 2: Normal wound healing process. From Eming, S.A., P. Martin, and M. Tomic-
Canic, Wound repair and regeneration: Mechanisms, signaling, and translation. Science 
Translational Medicine, 2014. 6(265): p. 265sr6-265sr6. Reprinted with permission from 
AAAS. 
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 In response to growth factors such as PDGF, TGF-β, and FGF; fibroblasts proliferate 
and produce new ECM materials e.g. collagen I & III, proteoglycans, and 
glycosaminoglycans [4]. Concurrently, capillary sprouts develop and begin to migrate into 
the wound, allowing for the transport of nutrients and oxygen to the surrounding tissues. 
Later in the proliferative stage, fibroblasts near the edge of the wound, differentiate into 
myofibroblasts, and overtime, close the wound. Remodeling of the microenvironment occurs 
over the next year as functionality is eventually restored to the damaged tissues. This is 
completed by altering ECM proteins from being mostly comprised of collagen III to collagen 
I via matrix metalloproteinases and the formation of collagen fiber bundles [9, 10].  
Chronic Wounds 
 Wound healing is a vastly complex process where the disturbance of any cellular or 
biochemical process could delay or prevent healing; bringing about chronic, non-healing 
wounds [5]. Non-healing wounds can develop at any time in the wound healing process i.e. 
inflammation, proliferation, and tissue remodeling. Healing oftentimes stalls during the 
inflammatory phase (Figure 3); as persistent inflammation causes an upregulation of pro-
inflammatory cytokines, creating an excessive number of proteases leading to ECM 
degradation [11]. During proliferation, inappropriate levels of macrophages, fibroblasts, and 
keratinocytes can stall the wound healing process [4, 6, 8]. Tissue hypoxia, infection, disease, 
and age are other factors that inhibit wound healing. As stated, wound healing is a complex 
process involving many different signals, cells, and tissues in which the slightest miscue can 
cause the development of a chronic wound.    
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Figure 3. Development of a chronic wound. From Eming, S.A., P. Martin, and M. Tomic-
Canic, Wound repair and regeneration: Mechanisms, signaling, and translation. Science 
Translational Medicine, 2014. 6(265): p. 265sr6-265sr6. Reprinted with permission from 
AAAS.  
Volumetric Muscle Loss 
 For an average individual, skeletal muscle accounts for more than 40% of the total 
body mass [12]. Traumatic injuries, surgical procedures, and other incidences of high tissue 
loss are a few instances where the body is not able to heal and results in partial or total loss of 
function. These types of wounds are classified as volumetric muscle loss (VML). VML has 
been highly problematic for the military and its effects are seen in recent military conflicts 
i.e. Operation Enduring Freedom and Operation Iraqi Freedom; where the majority of 
injuries sustained involve severe musculoskeletal injury [13]. Of all battlefield injuries, 54% 
of cases present extremity injuries, with soft tissue injures making up 53% of these cases. 
Due to these injuries countless military personnel have suffered partial or complete loss of 
function. VML cost the United States over 4 billion dollars in hospital expenses and loss of 
production (2010 data) [13]. VML not only affects military personnel but also civilians as an 
7 
estimated 4.5 million reconstructive surgeries involving tumor removals were completed in 
2017 [14]. These procedures remove massive sections of tissue; oftentimes, leading to tissue 
deformation and loss of function. Not only does VML have an enormous economic cost but it 
also bears a huge psychological burden on the patient and the patient’s family. The need for a 
viable treatment to VML has never been more pressing.  
Clinical Need 
 The standard of care is dependent upon the severity of the injury sustained, as 
bracing, tissue implantation, and regenerative strategies have been used to treat VML [3, 12, 
13, 15-17]. Tissue implantation i.e. autologous implantation is the preferred method for 
dealing with severe cases of VML. In autologous implantation a tissue graft is taken from the 
patient and is used to replace damaged tissues, while minimizing the immune response from 
the body. One disadvantage of this system is the lack of available autologous grafts. Research 
is being conducted on allogenic muscle grafts as a possible option; however, the possibility 
of disease transmission and graft rejection are inherent disadvantages to using an allogenic 
transplant [18]. Even with the possibility of negating an immune response; donor site 
morbidity, loss of strength, and decreased function are common issues that diminish the 
viability of tissue implantation. Complications such as infection and tissue necrosis, cause  
10% of these surgeries to fail [15]. While tissue implantation minimizes the immune 
response, better alternatives are needed to mitigate negative side effects and low implant 
availability. 
Regenerative Approaches 
 Regenerative medicine has been primarily focused on the development of scaffolding 
systems that mimic the ECM. These systems are designed to promote cell-biomaterial 
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interaction, control scaffold degradation and the exchange of important nutrients and growth 
factors, maintain mechanical stability with appropriately designed shape and 
microarchitecture, and elicit minimal response from the immune system [15, 19-22]. Current 
research focuses on the development of decellularized tissue scaffolds and the fabrication of 
polymeric scaffolds. 
Decellularized Tissue Scaffolds 
 Currently several decellularized tissue scaffolds (Table 1) have been approved by the 
FDA. These scaffolds, mostly derived from bovine or porcine animals, are rich in latent 
growth factors such as basic fibroblast growth factor (bFGF) and vascular endothelial growth 
factor (VEGF), and have been shown to alter the wound microenvironment from one that 
induces fibrosis to one that promotes remodeling [23, 24]. 
Table 1: FDA approved decellularized scaffolds [18, 23] 
 
 Prior to implantation, decellularization i.e. removal of all cellular material, is needed 
to prevent immune responses. Poor decellularization is characterized by a massive 
inflammatory response which inhibits or prevents healing [24]. Decellularization is a  harsh 
process and can affect the concentration of growth factors and proteins in these scaffolds 
Products Composition 
OASIS Wound Matrix ® Acellular porcine small intestine submucosa 
PriMatrix ® Acellular fetal bovine dermis 
GraftJacket ® Acellular human dermis 
Integra ® Bilayer matrix bovine collagen and silicon 
MatriDerm ® Bovine collagen fibrils with elastin 
MySkin Cultured autologous keratinocytes on membrane 
EpiCel ® Cultured autologous keratinocytes 
Theraskin 
Human allogenic split-skin graft with keratinocytes and 
fibroblasts 
Regranex ® Human recombinant platelet-derived growth factor 
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[15]. Along with limited availability, short shelf life, and inability to mass produce; 
alternative scaffold materials are needed. 
Polymeric Scaffolds 
 Polymeric scaffolds are composed of biological or synthetic polymers. Biological and 
synthetic polymers are currently used to create scaffolds with specific mechanical, chemical, 
and biological properties that are tailored to a particular microenvironment. A variety of 
biological and synthetic polymers (Table 2) are being researched as scaffolding materials. 
Not only can these scaffolds be fabricated with specific characteristics but they can be loaded 
with growth factors, proteins, and drugs to aid in wound healing. The bioactivity of 
biological polymers has been shown to link certain growth factors i.e. VEGF and hepatocyte 
growth factor, to the scaffold, aiding in regeneration [19]. However, these scaffolds suffer 
from poor mechanical properties and oftentimes are used in conjunction with synthetic 
materials to ameliorate their poor mechanical properties. 
Table 2: Polymers for scaffold fabrication 
Biological Polymers Synthetic Polymers 
Collagen Poly(glycolic acid) (PGA) 
Chitosan Poly-ε-caprolactone (PCL) 
Alginate Poly-l-lactic-acid (PLLA) 
Agarose Polylactic-co-glycolic-acid (PLGA) 
Fibrin Poly(lactic acid) (PLA) 
Gelatin Poly(lactide-co-glycolide) (PLG) 
Hyaluronic Acid Polypeptites 
Silk fibroin Poly(acrylic acid) (PAA) 
 Poly(ethylene oxide) (PEO) 
 Poly (β-amino ester) (PBAE) 
 
 Synthetic polymers have the benefit of tailorable degradation profiles and 
architecture; however, these materials are plagued by the fact that they do not readily allow 
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cell attachment and are known to stimulate the foreign body response [15, 25]. This issue can 
be minimized by the addition of different proteins or macromolecules i.e. arginine–glycine–
aspartic acid (RGD) peptides, to the scaffold’s microstructure [25, 26]. Due to variances in 
degradation and mechanical properties some polymers are suited for bone applications; 
whereas, others may be better suited for muscle or skin applications.  
Poly(β-Amino Ester) 
 Poly(β-amino ester)s (PBAE), a class of synthetic polymers, were originally 
developed for gene and DNA delivery [27-30]. Current research is focused on using PBAEs 
as a scaffolding material. PBAEs are composed by step-growth conjugate addition reaction 
of diacrylate and amine groups [31, 32] and are known to be biodegradable via hydrolysis of 
the ester bonds and biocompatible [27, 33]. The byproducts from PBAE degradation are 
several small nontoxic molecules which can be readily cleared prior to reaching toxic levels 
[27, 34, 35]. Dependent upon the diacrylate and amine groups, tailorable degradation 
profiles, mechanical properties and shapes can be synthesized [27, 28, 33]. Designing PBAEs 
with certain physical, chemical, and mechanical properties allows for a multitude of 
applications.  
Polymer Crosslinking 
 Different physical and chemical methods are being employed for polymeric 
crosslinking e.g. radical polymerization, high energy irradiation, enzymatic crosslinking, 
ionic interactions, and crystallization [36]. These different crosslinking methods allow for 
polymers to be fabricated with specific structure and properties. While these processes can 
crosslink polymers, they also produce unintended effects such as high cytotoxicity, low 
crosslinking, poor mechanical properties, etc. As such, choosing the method of crosslinking 
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is just as important as selection of the polymer. Photopolymerization is one of the primary 
methods used to crosslink polymeric materials. Despite toxic solvents and photoinitiators 
needed for crosslinking, UV irradiation is the primary crosslinking method for biomedical 
applications [37, 38]. To minimize the effect of harmful UV irradiation, current research has 
been working with different visible light irradiation sources i.e. green light, red light, and 
blue light (BL) [39-42]. One study is attempting to crosslink methacrylated hyaluronan with 
green light irradiation to act as an injectable tissue repair treatment system [41].  
Significance  
 The goal of this project was to develop and characterize a BL crosslinked PBAE, with 
the long term aim of in vivo crosslinking for VML applications. BL irradiation was chosen 
due to its slightly longer wavelength which has been shown to promote antimicrobial, 
antibacterial, and anti-inflammatory effects. [43-46]. In order for BL crosslinking to occur, a 
photoinitiator with an appropriate absorption spectra was selected. However, due to BL 
photoinitiator solubility issues, the BL crosslinking system was altered from the common UV 
crosslinking method to include BL irradiation and a water-soluble photoinitiator. With these 
changes, the BL system would be expected to minimize toxicity issues that the UV 
crosslinking method experienced.   
 The overall goal was to characterize BL PBAE scaffolds created by this method and 
compare it to the common UV crosslinking method. This was achieved by studying the 
systems physical and mechanical properties i.e. degradation and swelling profiles, changes in 
supernatant pH, Young’s modulus under tension and compression, and hydrogel 
microarchitecture.   
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METHODS AND MATERIALS 
Materials 
 Polyethylene glycol diacrylate (PEGDA 400) and diethylene glycol diacrylate 
(DEGDA) purchased from Polysciences, Inc. (Warrington, PA). Tetraethylene glycol 
diacrylate (TEGDA) purchased from TCI America (Portland, OR). Isobutylamine purchased 
from VWR international (Philadelphia, PA.). The photoinitiator (2,2'-Azobis[2-methyl-N-(2-
hydroxyethyl)propionamide] (VA-086) was purchased from Wako Pure Chemical Industries, 
Ltd. (Richmond, VA). 2,2-Dimethoxy-2-phenylacetophenone (DMPA) and Ketoprofen was 
purchased from Sigma-Aldrich, Inc. (St. Louis, MO). Dichloromethane (DCM) and ethanol 
(EtOH) purchased from Pharmco-AAPER (Shelbyville, KY). Vancomycin was purchased 
from Gold Biotechnology (St. Louis, MO).  
Macromer Synthesis 
 Polyethylene glycol diacrylate (H), diethylene glycol diacrylate (A) and tetraethylene 
glycol diacrylate (D) were reacted with isobutylamine (6) using a 1.2:1 molar ratio of total 
acrylate to amine to form five different macromers [33, 47-49].  
 
Figure 4: (A) Chemical structures of diacrylates and amine used to form macromers.  (B) 
Macromer synthesis reaction. 
A 
D 
H 6 
A 6 
Macromer A6 
(A) (B) 
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 Three single acrylate macromers were synthesized: H6, D6, and A6.  While 
maintaining the molar ratio of total acrylate to amine, two macromers were synthesized with 
a 3:1 ratio of D to H (DH6 3:1) or A to H (AH6 3:1). These chemicals were pipetted into a 
round bottom flask with a magnetic stirrer. The flask was then placed in a silicon oil bath at 
85°C and allowed to stir for 48 hours, at which point the reaction was quenched by cooling 
the macromer to 8° C. Macromer molecular weight was verified by gel permeation 
chromatography.  
Hydrogel Fabrication 
 Hydrogel samples were fabricated by free radical solution polymerization using either 
BL or UV to irradiate the solutions [33, 49]. For UV polymerization macromer solutions 
were synthesized by combining macromers with 1% (w/w) DMPA in 80% (w/w) DCM as 
compared to the macromer. For BL polymerization, macromer solutions followed similar 
preparation methods but the macromer was mixed with 2.8% (w/w) VA-086 in 80% (w/w) 
deionized water. To study the properties of both crosslinking systems, a variety of sample 
geometries were fabricated i.e., dogbones, discs, and cylinders.  Due to differences in shape 
and solution volume, irradiation times varied from shape to shape. For dogbones and discs, 
the macromer solutions were pipetted between two glass slides separated by a 1.7 mm thick 
Teflon spacer and irradiated for 5 minutes with UV or 20 minutes by BL. Once crosslinked 
samples were then cut with either a 7.5 mm diameter punch or an ASTM D-1708 standard 
microtensile sample die. For cylinders, the macromer solution was pipetted into a glass 
cylinder mold, 5.8 mm diameter, and irradiated, with UV or BL, for 1 hour while being 
circumferentially exposed to the light on an in-house built instrument. Samples were then 
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washed overnight in an ethanol bath and allowed to dry. Once dried, cylinder samples were 
cut to a height to diameter ratio of 1.5:1.   
PBAE Characterization 
In Vitro Degradation  
 After measuring their initial mass, hydrogel discs were placed into 48-well plates, 
immersed in 1 ml of phosphate-buffered saline (PBS), pH 7.4, and gently shaken at 37 °C. At 
hydrogel dependent time points, hydrogel and PBS supernatant samples were collected. PBS 
supernatant samples were stored in 3 ml aliquots at -20 °C. For all samples the PBS 
supernatant was renewed in order to prevent the buildup of acidic supernatants. Once 
removed, hydrogel samples were dried of excess PBS and the wet mass was measured and 
compared to its initial mass to determine the swelling ratio. Samples were then stored at -20 
°C for the duration of hydrogel degradation and then lyophilized for two days. Dry masses 
were then measured and compared to their initial masses to determine mass loss.  
Porosity 
 Hydrogel porosity was calculated by Scanco Medical X-ray microtomography 
(micro-CT). After dry mass measurements were taken, a triplicate of hydrogel samples from 
four specific degradation time points were taken and frozen at -20°C overnight and then 
lyophilized for two days. Samples were chosen to capture changes in hydrogel morphometry 
at critical points during degradation, i.e., the time points at the beginning, end, and before 
and after significant mass loss. Hydrogel microarchitectural differences were calculated by 
micro-CT analysis software. By measuring the area from each X-ray image, the micro-CT 
analysis software was able to calculate the porosity, pore size, and wall thickness between 
pores in the crosslinked hydrogels.  
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Mechanical Testing 
 Evaluation of hydrogel modulus was accomplished by using a Bose Electroforce 
3300 series test instrument with a 225 N force sensor measuring the load and deformation 
under confined compression and tensile testing. A strain rate of 0.05 mm/s and a preload of 
0.1 N was selected for both compression and tensile testing. For compression and tensile 
sample geometries refer back to the hydrogel fabrication section, page 13. For compression 
testing, metal compression heads were mounted to the Bose system. Cylinder samples were 
then placed between two compression heads and compressed to 30% strain. For tensile 
testing, grips were attached to the movable heads of the Bose system. Silicone spacers were 
placed on both sides of the dogbone head, as to minimize failure and slippage near the grip 
section. Samples were placed in the grips and stretched to remove slack. The sample was 
then placed under tension until failure. For each sample run, the time (s), displacement (mm), 
and load (N) were collected in order to calculate the modulus. The modulus was calculated 
from the initial linear elastic region of the stress-strain curve.  
Drug Release Pilot Study 
 DH6 (BL) 3:1 and DH6 3:1 were studied for their respective release patterns. DH6 
(BL) 3:1 was loaded with vancomycin while DH6 3:1 was loaded with ketoprofen. Both 
drugs were loaded at 10% (w/w) as compared to the macromer. After crosslinking, 7.5mm 
diameter samples were punched and placed into a 48-well plate and immersed in PBS. Every 
twelve hours supernatant was withdrawn, put into 6 ml tubes, and frozen. After a four day 
collection period, samples were thawed and measured by a BioTek PowerWave HT UV-Vis 
plate reader. Drugs were measured at different wavelengths: vancomycin (280 nm) and 
ketoprofen (310 nm).   
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Statistical Analysis 
 A two-way analysis of variance (ANOVA) and Tukey’s HSD post-hoc was run using 
R studio to statistically analyze the results for in vitro degradation and micro-CT studies. For 
mechanical testing, two-way ANOVA and multiple comparison post-hoc analysis was run 
using Matlab. Statistical significance was established at p values less than 0.05.  
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RESULTS 
Degradation Study 
PBAE Degradation & Swelling Profiles 
 PBAEs showed predictable degradation profiles, which exhibited minimal mass loss 
prior to a hydrogel-specific critical point, i.e. A6 day 30, D6 day 10, AH6 3:1 day 3.5, DH6 
3:1 day 1.5, and H6 two hours, after which the samples began to rapidly lose mass, as seen in 
Figure 5 (a). Likewise, these critical points are near the maximum swelling of the hydrogels 
as seen in Figure 5 (b). 
  
18 
 
Figure 5: Polymer degradation (a) and swelling (b) profiles for all UV hydrogels. Data are 
mean ± standard deviation (n = 9). 
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BL and UV Degradation Profiles 
 BL and UV hydrogels follow the typical degradation profile as seen in Figure 1.1, but 
BL hydrogels are shown to degrade differently compared to their UV counterparts: AH6 
(BL) 3:1 degraded slower, H6 (BL) degraded quicker, and DH6 (BL) 3:1 degraded at the 
same speed (Figure 6). Two-way ANOVA showed statistically significant differences with 
respect to time point, crosslinking method, and the interaction between time point and 
crosslinking method (p < 0.05). 
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Figure 6: BL and UV degradation profiles for hydrogels (a) AH6 3:1, (b) DH6 3:1, and (c) 
H6. Data are mean ± standard deviation (n = 9). Data sets AH6 3:1 and H6 exhibit UV and 
BL degradation curves which are statistically different (p< 0.05) after time point day 4 and 
hour 1.25, respectively. 
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BL and UV Swelling Profiles 
 BL and UV PBAEs displayed significant differences when it came to swelling 
behavior, swelling from four to eight times their original mass (Figure 7). Two-way ANOVA 
shows that AH6 3:1, DH6 3:1, and H6 BL hydrogels were significantly different from their 
UV counterparts with respect to time point, crosslinking method, and the interaction between 
time point and crosslinking method (p < 0.05). 
  
22 
 
Figure 7: BL and UV swelling profiles for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are 
mean ± standard deviation (n = 9). All data sets are significantly different (p < 0.001) after 
time point day 1.26 (AH6 3:1), day 1.5 (DH6 3:1), and hour 0.66 (H6). 
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X-ray microtomography 
 MicroCT showed changing microarchitecture within the hydrogels during 
degradation. Throughout degradation BL hydrogels showed increasing porosity (Figures 8a), 
consistent pore sizes (Figure 8b), and decreasing wall thickness between pores (Figure 8c).  
Two-way ANOVA showed statistically significant differences between BL and UV 
hydrogels (Figure 9) showing statistical differences in porosity, pore size and wall thickness 
(p < 0.05) 
.  
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Figure 8: Hydrogel porosity, pore size, and wall thickness between pores shown. Data are 
mean ± standard deviation (n = 3).  
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Figure 9: Evaluating hydrogel microarchitecture of BL and UV crosslinking methods. Data 
points which are significantly different are marked with a bar and asterisks (*) (p < 0.05).    
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pH Profiles 
 The supernatant for hydrogels A6 and D6 started at a pH of 7.4, but near the critical 
point of mass loss, the pH dropped to a pH of 6.5 and then rose back to a pH of 7 (Figure 10). 
Instead of following this pattern, the other hydrogels, AH6 3:1, DH6 3:1, and H6, started 
with a pH slightly above 7.4 and showed a  0.5 pH unit drop over the span of degradation 
(Figure 11). Two-way ANOVA showed a statistically significant difference with respect to 
time point, crosslinking method, and the interaction between time point and crosslinking 
method (p < 0.05).  
 
Figure 10: pH of the hydrogel supernatant for A6 and D6. Data are mean ± standard 
deviation (n = 3). 
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Figure 11: pH measurements for (a) AH6 3:1, (b) DH6 3:1, and (c) H6. Data are mean ± 
standard deviation (n = 3). Data points which are significantly different (p < 0.05) are marked 
with asterisks (*).  
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Mechanical Study 
Compressive and Tensile Modulus 
 Load-deformation curves (Figure 12) were used to construct compressive (Figure 
13a) and tensile (Figure 13b) stress-strain curves. These curves were then used to calculate 
the mean (Figure 14) and average (Table 3) modulus. BL hydrogels exhibited decreased 
compressive and tensile modulus as compared to UV crosslinked hydrogels. Two-way 
ANOVA showed statistically significant differences between crosslinking methods with BL 
and UV hydrogels AH6 3:1 and DH6 3:1 being statistically different (p < 0.05). 
 
Figure 12: Representative load-deformation curves for (a) compression and (b) tensile testing 
of sample AH6 3:1 
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Figure 13: Representative stress-strain curves for (a) compression and (b) tension. Red line 
indicates the slope of the given data used for calculating the modulus.  
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Figure 14: Modulus for (a) compression and (b) tension. Data are mean ± standard deviation 
(n = 4). Outliers are denoted by red plus signs. 
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Table 3: Average modulus of hydrogels.  
Hydrogel  Average Compressive Modulus (KPa) Average Tensile Modulus (KPa) 
A6  1633 ± 607 801 ± 192 
D6  1489 ± 725 835 ± 117 
AH6 3:1*  1589 ± 499  821 ± 251 
AH6 (BL) 3:1*  291 ± 204 279 ± 135 
DH6 3:1*  1087  ± 798 776 ± 182 
DH6 (BL) 3:1*  281 ± 194 160 ± 81 
H6  840 ± 279 337 ± 129 
H6 (BL)  313 ± 58 201 ± 96 
     * BL and UV crosslinked hydrogel means which are statistically different are marked with 
 asterisks (*) (p < 0.05)      
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Drug Release Pilot Study 
Vancomycin and ketoprofen release from DH6 3:1 hydrogels. Vancomycin-loaded DH6 (BL) 
3:1 hydrogels showed an initial burst release with a slow continual release until the end of the 
study. Ketoprofen-loaded DH6 3:1 hydrogels showed variable release patterns with a burst-
like release in the middle of the study and an average release of almost four times that of 
vancomycin (Figure 15).   
 
 
 
Figure 15: Release of vancomycin and ketoprofen from DH6 3:1 BL and UV hydrogels, 
respectively (n = 1).  
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DISCUSSION 
 Poly(β-amino ester)s, originally developed for gene and DNA delivery applications, 
have drawn significant interest as a scaffolding material. PBAEs have been previously 
reported as a safe biocompatible material [50, 51], with tailorable degradation profiles [33] 
and a wide range of mechanical properties [52]. In dealing with soft tissue injuries, 
appropriate degradation times and mechanical properties are necessary for tissue regeneration 
and cell penetration. Wound healing can take up to a year, depending upon the severity of the 
wound. Therefore, overall degradation needs to span a couple of weeks to allow the 
surrounding tissues enough time to replace the scaffold while not inhibiting tissue 
regeneration [15, 52-54]. In one study complete skeletal muscle formation occurred in 5 days 
[54]. BL PBAEs AH6 3:1 and DH6 3:1 lost 20% and 42% of their initial mass over 9.5 and 
3.5 days, while their UV counterparts lost 41% and 50% of their initial mass over the same 
time, respectively. The degradation profiles for these PBAEs are shown to be appropriate for 
the formation of new skeletal muscle. Appropriate mechanical properties are also needed as 
they have been shown to influence cellular interactions i.e. cell adhesion and contractility 
[55], affect properties i.e. swelling [52], and  play a key role in the wound healing process 
[56]. Skeletal muscle has been shown to have an average Young’s modulus of ~10 kPa [57-
59] but has shown maximum values nearing 60 kPa [57, 59]. BL PBAEs AH6 3:1 and DH6 
3:1 exhibited an average tensile modulus of 279 ± 135 kPa and 160± 81 kPa which is vastly 
decreased  from the average tensile modulus of 821 ± 251 kPa and 776 ± 182 kPa posted by 
their UV counter parts. 
 PBAE degradation profiles and mechanical properties can be altered by changing 
either the diacrylate or amine in the macromer. In this research, varying the diacrylate elicited 
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different mechanical strengths and tailorable degradation profiles. Each diacrylate had a 
variance in the number of oxygens located in their monomer chain; see Figure 4 on page 12. 
This difference directly affected the hydrophobicity of the macromer, as having more oxygen 
in the monomer chain led to faster overall swelling and degradation.  
 Macromer molecular weight plays a role in PBAE degradation, swelling, and 
mechanical strength [27, 60]. Decreases in macromer molecular weight  have been shown to 
cause increased crosslink density [28], therefore increasing the modulus and decreasing 
overall time of degradation. Variances in molecular weight allow for the formation of 
matrices with slightly different crosslink densities, which could cause minor variances in 
degradation, swelling, and mechanical properties. While macromer molecular weight could 
have an effect on degradation, swelling, and mechanical properties of PBAEs, it was not a 
focus of this research.  
 UV photopolymerization is the most common method of polymer crosslinking. This 
system boasts quick reaction times, with minimal heat production under physiological 
temperatures resulting in uniform hydrogel properties [61, 62]. This method is a double 
edged sword, as free radicals are needed for polymer crosslinking; yet, prolonged exposure to 
irradiation and  free radicals [62] cause issues such as radiation safety and curing depth 
limitations [63]. Interest in visible light irradiation sources i.e. BL, have seen increased 
interest due to increased irradiation safety and energy utilization efficiency [63].  
 BL photopolymerization elicits different physical and mechanical properties as 
compared to the standard method. In this research BL crosslinking was impossible for two of 
these macromers: A6 and D6. These macromers were composed of diacrylates that had lower 
number of oxygens in their macromer chain which resulted in increased macromer 
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hydrophobicity. Attempting to mix the macromer with the aqueous photoinitiator solution 
resulted in a heterogeneous mixture which failed to crosslink. AH6 3:1 and DH6 3:1 faced 
similar issues but mixed completely, resulting in an opaque viscous solution which at times 
had difficulty crosslinking. H6 mixed completely and resulted in a transparent solution with 
an increased amount of gas bubbles. 
 The PBAEs formed from the BL crosslinking process displayed differences in 
degradation, swelling, and mechanical properties. The properties exhibited by these PBAEs, 
from their mechanical strength to degradation profile, are controlled by their specific 
structure. The combination of hydrophobicity, crosslink density, and microarchitecture 
induce hydrogel specific properties. 
 Hydrophobicity is one of the main factors affecting the structure and properties of 
these PBAEs. BL PBAEs are greatly impacted by macromer hydrophobicity, as hydrophobic 
macromers have increased difficulty in mixing homogenously. This interaction created an 
opaque gaseous slurry, which could be the source of poor crosslinking and increased porosity 
and pore size. Degradation and swelling profiles are often dependent upon the 
hydrophobicity of their polymer, as the hydrophobic effect regulates the rate at which water 
interacts with the ester bonds. This interaction could explain why H6 BL degrades nearly two 
hours faster than its UV counterpart, as a good fraction of the bonds holding the matrix 
together may have already undergone hydrolysis during the fabrication process. The other 
BL hydrogels do not degrade as such, and are affected by other degradation factors affecting 
the structure of the hydrogel.  
  Crosslink density contributes to the different properties seen in BL PBAEs, 
specifically mechanical properties. BL PBAEs were difficult to handle as they would 
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oftentimes remaining tacky to the touch and tear easily. This suggests poor crosslinking has 
occurred, which has been correlated to decreased mechanical strength, increased swelling, 
and faster overall degradation [64-68]. BL hydrogels follow this trend seeing decreased 
mechanical strength and a massive increase in swelling; however, BL hydrogels AH6 3:1 and 
DH6 3:1 deviate from this pattern seeing degradation profiles which initially mimicked UV 
hydrogels but near the end of degradation began to see statistically different measurements. 
In this case poor crosslinking does not act as the main affecter, as poor crosslinking should 
cause a decrease in overall time of degradation, not an increase. A possible explanation for 
the slower overall degradation profile is the formation of hydrophobic aggregates. The 
degree to which the macromer and water mixed is unknown and could have resulted in the 
formation of a heterogeneous matrix with hydrophobic aggregates. These areas would inhibit 
water infiltration and thus slow degradation.  
 As seen in the results section, BL hydrogels have higher initial porosities and pore 
sizes, seeing increases in both throughout degradation; whereas, UV hydrogels maintained 
minimal porosity and constant pore sizes. H6 did not follow this trend, as both UV and BL 
samples had similar porosities and pore sizes throughout degradation. Hydrogel 
microarchitecture has been shown to influence mechanical strength and swelling capacity, as 
increased porosity and pore size indicate increased swelling ratios [67, 69] and decreased 
mechanical strengths [65, 66, 69].   
 During the degradation process there is a point prior to hydrogel mass loss that sees 
alterations in degradation, swelling, and pH profiles. Beyond this critical point, the hydrogel 
loses mass at a significant rate, sometimes losing as much as 30% of the original mass within 
a few measurements. At this point during degradation, there is a noticeable drop in pH for 
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two of the more hydrophobic hydrogels: A6 and D6. All other hydrogels see only a slight 
drop in the pH over the period of degradation. During the process of hydrolysis, ester bonds 
are broken down into carboxylic acid and an alcohol. One possibility for the difference in pH 
between hydrogels is different rates of PBAE degradation. Different PBAE degradation rates 
would cause different rates of acid production possibly explaining the buildup of acid in 
PBAEs A6 and D6. While there are periods of increasing acidity, the body is able to regulate 
the pH of the interstitial fluid thus clearing any acidic build up from the body. A stable pH 
level is critical for the scaffolds integrity and biocompatibility, as too much acidic stress 
could induce an inflammatory response preventing proper integration and eventually leading 
to massive fibrosis.  
 BL PBAEs demonstrate the ability to release drug from their matrix in a controllable 
manor. Controlled release of drugs or growth factors to attain therapeutic levels is a high 
priority in the field of tissue engineering. With controllable degradation and swelling 
profiles, PBAEs exhibit their ability to release growth factors and other therapeutic drugs for 
tissue regeneration applications [70, 71]. Current PBAE systems utilize an organic solvent 
system which lacks the ability to homogenously distribute water-soluble drugs throughout 
the scaffold. BL PBAEs are able to achieve uniform water-soluble drug distribution. 
Vancomycin and ketoprofen were used to look at the release patterns of drugs from the BL 
and UV crosslinked PBAEs. These drugs were selected for their solubility in each solvent 
system. PBAEs released their respective drugs at slightly different levels at different times. 
UV samples seemed to release a majority of their drugs near the end of the study while BL 
hydrogels tended to release their drug at the beginning of the study. Vancomycin is relatively 
larger than ketoprofen; however, the difference in size does not seem to play a major role in 
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the release of these drugs. If size played a role then ketoprofen, being the smaller molecular 
weight drug, would release most of the drug at the beginning of the study. One explanation is 
differences in hydrogel structure. BL hydrogels have been shown to be poorly crosslinked 
leading to the possibility of early release from the matrix; whereas, UV hydrogels have an 
increased crosslink density allowing for the drug to stay longer inside of the matrix. BL 
hydrogels released a lower amount of total drug suggesting poor loading. One explanation for 
the lower drug release is the EtOH washing phase. As the hydrogel undergoes washing to 
remove any unreacted monomers and photoinitiator solutions, the drug may have been 
washed away as well only leaving the strongly entrenched drug molecules behind. As a proof 
of concept, drugs can be loaded and released from the BL hydrogels. 
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CONCLUSION 
 Understanding how changes in hydrogel structure and properties affect their function 
gives great insight to their possible applications. The aim of this project was to develop a 
hydrogel system with the future aim being a regenerative strategy for wound healing 
applications. This research developed BL PBAE hydrogels and evaluated the differences 
between UV and BL hydrogels. BL PBAEs exhibit increased swelling ratios, prolonged 
degradation, and a decreased modulus. The properties of these PBAEs have mechanical 
strengths and degradation profiles that are appropriate for use in skeletal muscle scaffolding 
systems. BL PBAEs could be used in drug delivery applications for the delivery of water-
soluble drugs due to their degradation and swelling profiles. Further study is needed to attain 
appropriate mechanical properties and evaluate the possible drug release applications of BL 
PBAEs. 
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APPENDIX 
CELL STUDIES  
Materials 
 Trypan blue and Dulbecco’s modified Eagle’s medium (DMEM) purchased from 
HyClone (Logan, UT). Thiazolyl blue tetrazolium bromide (MTT reagent), Bovine Serum 
Albumin (BSA), and Hoechst 33258 purchased from Thermo Fisher Scientific Chemicals 
Inc. (Ward Hill, MA).,  Fibronectin, collagen I, collagen III, and tenascin C  purchased from 
Millipore Sigma (Burlington, MA). 
Methods 
 To understand how different ECM backgrounds alter cellular proliferation and 
attachment; a comparison between the regenerative Acomys (SM1) and the non-regenerative 
Mus musculus (M2) was completed. Immortalized fibroblast cell lines from these animals 
were seeded on different coating backgrounds and assayed. Six different coating 
backgrounds were selected for this study: fibronectin, collagen I, collagen III, tenascin C, 
bovine serum albumin (BSA), and tissue culture plastic (TCP).  
Table 4: Protein Concentration 
Protein Concentration (μg/ml) 
Tenascin C 1.52 
Fibronectin 1.73 
Collagen I 1.73 
Collagen III 1.17 
Albumin 0.92 
 
 These ECM protein backgrounds were coated on 24-well TCP plates at 
concentrations to obtain a surface density that would form a protein monolayer (Table 3) [72, 
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73]. Each well was coated by adding 100 μL of an individual protein concentration and were 
given two hours at room temperature for protein adsorption. The plates were then washed 
twice with PBS and a 5% BSA in PBS blocking solution was applied for 2 hours at room 
temperature. Wells were washed with PBS two more times and air dried and stored at 2-8 °C 
for future use. Both cell lines were detached and seeded using basic cell culture methods. The 
attachment assay was seeded at 40,000 cells per well, while the proliferation assay was 
seeded at 1.000 cells per well.  
 Both assays were allowed to run for specified times as to observe the attachment and 
proliferation of the individual cell lines. The attachment assay had four time points at 0.5, 1, 
2, and 4 hours, while the proliferation assay was measured once daily for six days. The 
assays were measured using the Hoechst DNA quantification protocol [74]. At the time of 
lysis, cells are washed twice with PBS, and 1 ml of a lysis buffer (0.05 M NaH2PO4, 2 M 
NaCl, 2 mM EDTA, pH 7.4) was added. Each well was sonicated two times for 10 seconds, 
and 0.25 ml of 2 μg/ml Hoechst 33258 was added to each well, shaken gently, and left at 
room temperature in the dark for 10 minutes. Fluorescence was measured at λex = 356 nm 
and λem = 458 nm.  
Preliminary Results 
 Initial results showed differences in attachment and proliferation, both qualitatively 
and quantitatively. Mus fibroblasts showed to attach quicker and at higher numbers, while 
Acomys fibroblasts showed increased proliferation. Prior to starting the study was unable to 
keep healthy low passage cell lines. Study was halted as to focus on material study. Two-way 
ANOVA showed statistical differences in proliferation between Acomys and Mus fibroblasts 
(p = 0.05); however, attachment was not statistically different. 
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Figure 16: Mus and Acomys fibroblast (a) attachment and (b) proliferation studies. Cells 
were seeded at 40K and 1K for attachment and proliferation studies. Red line indicates cell 
seeding. Data are mean ± standard deviation (n=3). 
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Discussion 
 There is a prevalent need to understand how cellular attachment and proliferation are 
affected by different protein backgrounds. Understanding cellular responses to different 
protein backgrounds will allow future work to focus on the best protein combination to aid in 
a wound healing environment. 
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